HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
TUESDAY, Sept. 24, 2019 (HealthDay News) -- Among older individuals with type 2 diabetes, those with poor health have more prevalent insulin use, according to a study published online Sept. 23 in JAMA Internal Medicine.
Jonathan Z. Weiner, M.D., M.P.H., from Kaiser Permanente of Northern California in Oakland, and colleagues examined insulin use among older individuals with type 2 diabetes with poor versus good health in a longitudinal cohort study involving 21,531 individuals followed for up to four years. Insulin treatment and glycemic control were characterized over time using electronic health record data.
The researchers found that 18.9 percent of the patients used insulin. At age 75 years, the prevalence and adjusted risk ratios (aRRs) of insulin use were higher in individuals with poor health and intermediate health relative to good health (29.4 and 27.5 percent, respectively, versus 10.5 percent; aRRs, 2.03 and 1.85, respectively). Overall, 32.7 percent of insulin users at age 75 discontinued insulin within four years of entering the cohort. Individuals with poor and intermediate versus good health had a higher likelihood of continued insulin use (aRRs, 1.47 and 1.16, respectively). In the subset with tight glycemic control, the same prevalence and discontinuation patterns were present.
"The substantial and persistent insulin use among older adults with a high risk of hypoglycemia and limited future benefit suggests that more work is needed to develop systems-based approaches that support guideline-concordant insulin use in people older than 75 years," the authors write.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 26, 2022